Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q1 2024 Earnings Presentation

16 slides from Chemours Company (the)'s earnings presentation, May 1, 2024

  1. Slide 1: First Quarter 2024 Earnings Presentation

    First Quarter 2024 Earnings Presentation April 30, 2024

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: First Quarter 2024 Financial Summary

    First Quarter 2024 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) ∆ First Quarter vs Prior-Year Quarter 1Q24 1Q23 Yr/Yr  Net Sales: Decreased by 12% to $1.4 billion, driven by decreased volumes in APM and TSS Net Sales $1,350 $1,536 $(186) as well as lower pric

  4. Slide 4: Adjusted EBITDA Bridge: 1Q24 versus 1Q23

    Adjusted Adjusted EBITDA EBITDA Bridge: Bridge: 1Q24 versus 4Q22versus 4Q21 1Q23 ($ in millions unless otherwise noted) First Quarter vs Prior-Year Quarter • Price Declines: Primarily driven by lower pricing in market-exposed customer portfolio within the TT segment, as well as lower pricing in lega

  5. Slide 5: Liquidity Position as of March 31, 2024

    Liquidity Position as of March 31, 2024 Liquidity Position Adjusted EBITDA Bridge: 4Q22 versus 4Q21 ($ in millions unless otherwise noted) Q1’24 Cash Flow Highlights: Gross debt Q1’24 Cash Position: $4.1B • Operating Cash Flow: $(290) million • Unrestricted Cash: $0.7 billion Net Debt 9 $3.3B • Cape

  6. Slide 6: Segment Performance

    Segment Performance

  7. Slide 7: Titanium Technologies (TT) Business Summary

    Titanium Technologies (TT) Business Summary ($ in millions) Q1 Highlights Q1 Net Sales  Q1 Performance: YoY Net Sales decreased due to declines in Total Price Volume Currency market-exposed customer portfolio, partially offset by index-based Yr/Yr % (7) (7) 0 0 priced contractual stability. Volumes

  8. Slide 8: Thermal & Specialized Solutions (TSS) Business Summary

    Thermal & Specialized Solutions (TSS) Business Summary ($ ($ in in millions) Q1 Highlights millions) Q1 Net Sales  Q1 Performance: YoY Net Sales decrease driven by lower Auto Total Price Volume Currency OEM and FP&O* portfolio demand coupled with lower legacy HFC Yr/Yr % (8) (2) (6) 0 and contractu

  9. Slide 9: Thermal & Specialized Solutions – Business Summary

    Thermal & Specialized Solutions – Business Summary TSS Market Strength TSS Key End Markets Global leading provider of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents Category leader in next-gen low global warming potential (“GWP”) refrigerant tech

  10. Slide 10: Two-Phased Data Center Immersion Cooling with Opteon

    Two-Phased Data Center Immersion Cooling with Opteon  Over 95% of data centers use traditional air- and water-cooled technologies The Technology  Data centers are highly energy-intensive, with over 40% of energy dedicated to cooling IT equipment Key Market  A mid-sized US data center consumes app

  11. Slide 11: Advanced Performance Materials (APM) Business Summary

    Advanced Performance Materials (APM) Business Summary ($ in millions) Q1 Highlights Q1 Net Sales  Q1 Performance: YoY Net Sales decline driven by weaker demand in Total Price Volume Currency more economically sensitive and non-strategic end-markets and the tail Yr/Yr % (23) (5) (18) 0 impact of an

  12. Slide 12: Appendix

    Appendix

  13. Slide 13: Segment Net Sales and Adjusted EBITDA (Unaudited)

    Segment Net Sales and Adjusted EBITDA (Unaudited) ($ in millions) Three Months Ended Three Months Ended March 31, December 31, 2024 2023 2023 SEGMENT NET SALES Titanium Technologies $ 588 $ 632 $ 651 Thermal & Specialized Solutions 449 486 374 Advanced Performance Materials 299 388 325 Other Segment

  14. Slide 14: GAAP Net Income to Adjusted Net Income, Adjusted EBITDA Reconciliation (Page 1/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Month

  15. Slide 15: GAAP Net Income to Adjusted Net Income, Adjusted EBITDA Reconciliation (Page 2/2)

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Month

  16. Slide 16: Thank you!

    Thank you!

Chemours Company (The) — Q1 2024 Earnings Presentation on 6ix